Native Mass Spectrometry Reveals Binding Interactions of SARS-CoV-2 PLpro with Inhibitors and Cellular Targets

ACS Infect Dis. 2024 Oct 11;10(10):3597-3606. doi: 10.1021/acsinfecdis.4c00444. Epub 2024 Sep 20.

Abstract

Here we used native mass spectrometry (native MS) to probe a SARS-CoV protease, PLpro, which plays critical roles in coronavirus disease by affecting viral protein production and antagonizing host antiviral responses. Ultraviolet photodissociation (UVPD) and variable temperature electrospray ionization (vT ESI) were used to localize binding sites of PLpro inhibitors and revealed the stabilizing effects of inhibitors on protein tertiary structure. We compared PLpro from SARS-CoV-1 and SARS-CoV-2 in terms of inhibitor and ISG15 interactions to discern possible differences in protease function. A PLpro mutant lacking a single cysteine was used to localize inhibitor binding, and thermodynamic measurements revealed that inhibitor PR-619 stabilized the folded PLpro structure. These results will inform further development of PLpro as a therapeutic target against SARS-CoV-2 and other emerging coronaviruses.

Keywords: PLpro; SARS-CoV protease; inhibitor; mass spectrometry; protein−protein interactions; ultraviolet photodissociation.

MeSH terms

  • Antiviral Agents* / chemistry
  • Antiviral Agents* / pharmacology
  • Binding Sites
  • COVID-19 / virology
  • Coronavirus 3C Proteases / antagonists & inhibitors
  • Coronavirus 3C Proteases / chemistry
  • Coronavirus 3C Proteases / genetics
  • Coronavirus 3C Proteases / metabolism
  • Coronavirus Papain-Like Proteases* / antagonists & inhibitors
  • Coronavirus Papain-Like Proteases* / chemistry
  • Coronavirus Papain-Like Proteases* / metabolism
  • Cytokines / metabolism
  • Humans
  • Mass Spectrometry
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology
  • Protein Binding
  • SARS-CoV-2* / drug effects
  • SARS-CoV-2* / genetics
  • SARS-CoV-2* / metabolism
  • Ubiquitins / chemistry
  • Ubiquitins / genetics
  • Ubiquitins / metabolism

Substances

  • Antiviral Agents
  • Coronavirus 3C Proteases
  • Coronavirus Papain-Like Proteases
  • Cytokines
  • ISG15 protein, human
  • papain-like protease, SARS-CoV-2
  • Protease Inhibitors
  • Ubiquitins